0% found this document useful (0 votes)
15 views5 pages

Case Study - Edited (1) .Edited

Uploaded by

klm klm
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
15 views5 pages

Case Study - Edited (1) .Edited

Uploaded by

klm klm
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 5

1

Follow-up Visit Case Study

Student

Institution

Course

Instructor

Date
2

Follow-up Visit Case Study

Identification of the Dermatological Condition

Observations made are erythematous/vesicular patterning over the distribution of the

ophthalmic division of the trigeminal nerve, which is painful upon touch. Considering the

clinical symptoms and histories, the diagnosis critically pointed out is herpes zoster

ophthalmicus. This condition is presented as a recurrent varicella-zoster virus infection; a

unilateral dermatomal rash characterizes it. Thus, the rash is commonly present in the area of the

forehead, upper lid, and nose, and occasionally, there could be involvement of the eyes, which

may cause complications.

Differential Diagnoses

Similar diseases include herpes simplex virus infection, bacterial conjunctivitis with skin

rash, and skin contact dermatitis. In some individuals infected with HSV, it presents with small

grouped vesicles but does not present the dermatomal distribution of herpes zoster ophthalmicus

(Minor & Payne, 2021). Herpes simplex virus can cause bacterial conjunctivitis characterized by

eye redness and discharge, not vesicles. Contact dermatitis can cause erythema and irritation;

however, this condition is symptomatic of an external contact allergen or irritant and is not

evidence of reactivation of infection.

Diagnosis

Herpes zoster ophthalmicus is usually diagnosed clinically depending on the symptoms

displayed by the patient. Typically, the rash is spread according to the distribution of the

ophthalmic nerve, and other symptoms like pain or tingling prior to the appearance of a rash are

valuable clinical clues (Xiao et al., 2023). These include Hutchinson's sign, in which one has

lesions on the tip of the nose, meaning ocular involvement is impending. Clinical examination
3

can be conclusive, but if the need arises, a PCR or direct fluorescent antibody staining test can be

done to ascertain the existence of the varicella-zoster virus.

Treatment Plan

The initial treatment for herpes zoster ophthalmicus is antiviral medication, pain

medication, ophthalmic examination, and maybe corticosteroids. ACS-approved medications,

including acyclovir (800 mg five times a day), valacyclovir (1,000 mg three-time-a-day), or

famciclovir (500 mg three-time-a-day) for 7-10 days should also be prescribed to reduce viral

replication and any arising complications (Minor & Payne, 2021). Analogously, the management

of pain is essential, allowing the use of NSAIDs or other medications such as gabapentin or

pregabalin in case of postherpetic neuralgia.

Inflammations like keratitis or uveitis must prompt an eye specialist to evaluate the client

further. In severe cases of inflammation, corticosteroids can be prescribed by the

ophthalmologist. Also, the herpes zoster vaccine (Shingrix) should be taken by people over fifty

to reduce the recurrence of the coition's recurrences.


4

References

Minor, M., & Payne, E. (2021). Herpes Zoster Ophthalmicus. PubMed; StatPearls Publishing.

https://www.ncbi.nlm.nih.gov/books/NBK557779/

Xiao, Z., Wu, H., Chen, X., Chen, X., Yu, R., & Chen, A. (2023). Herpes Zoster Ophthalmicus

Clinical Presentation and Risk Factors for Lesion Recovery. Clinical, Cosmetic and

Investigational Dermatology, 16, 3767–3773. https://doi.org/10.2147/CCID.S444766


5

References

Litchman, G., Nair, P. A., Atwater, A. R., & Gossman, W. G. (2023). Contact dermatitis.

PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459230/

Ward, H., Parkes, N., Smith, C., Kluzek, S., & Pearson, R. (2022). Consensus for treating Tinea

Pedis: A Systematic Review of Randomised Controlled Trials. Journal of Fungi, 8(4),

351. https://doi.org/10.3390/jof8040351

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy